Forefront Analytics, LLC
Position in BCYC — Bicycle Therapeutics PLC
CIK 1696802
WEST CONSHOHOCKEN, PA
Position in BCYC
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$66,788
-$27,878 QoQ
Shares Held
14,394
+7.7% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Forefront Analytics, LLC holds $1,546,861 across 10 Biotechnology names. BCYC ranks #8 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
4,233 | $398,409 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
460 | $355,414 | |
| 3 | LEGN |
Legend Biotech Corp
|
15,659 | $283,271 | |
| 4 | NKTX |
Nkarta, Inc.
|
43,835 | $92,491 | |
| 5 | ZURA |
Zura Bio Ltd
|
14,901 | $88,660 | |
| 6 | GERN |
Geron Corp
|
55,125 | $82,136 | |
| 7 | ANNX |
Annexon, Inc.
|
14,240 | $78,889 | |
| 8 | BCYC |
Bicycle Therapeutics PLC
This page
|
14,394 | $66,788 |
All Filings in BCYC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,788 | 14,394 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $94,666 | 13,371 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||